References
Ahles, T. A., & Saykin, A. (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3(Suppl. 3), S84-S90.
Barsevick, A. M. (2007). The elusive concept of the symptom cluster. Oncology Nursing Forum, 34(5), 971-980.
Capuron, L., Gumnick, J. F., Musselmam, D. L., Lawson, D. H., Reemsnyder, A., Nemeroff, C. B., et al. (2002). Neurobehavioral effects of interferonalpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 26(5), 643-652.
Pollmacher, T. M., Haack, M., Schuld, A., Reichenber, A., & Yirmiya, R. (2002). Low levels of circulating inflammatory cytokines—Do they affect human brain functions? Brain, Behavior, and Immunity, 16(5), 525-532.
Wichmann, M. W., Meyer, G., Adam, M., Hochtlen-Volmar, W., Angele, M. K., Schalhorn, A., et al. (2003). Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer. Diseases of the Colon and Rectum, 46(7), 875-887.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002). Cytokines and cognition—The case for a head-to-toe inflammatory paradigm. Journal of the American Geriatric Society, 50(12), 2041-2056.
Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Myers, C. A., et al. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97(11), 2919-2925.
Dantzer, R. (2001). Cytokine-induced sickness behavior: Mechanisms and implications. Annals of the New York Academy of Sciences, 933, 222-234.
Dantzer, R. (2004). Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. European Journal of Pharmacology, 500(1-3), 399-411.
Dantzer, R. (2006). Cytokine, sickness behavior, and depression. Neurologic Clinics, 24(3), 441-460.
Dantzer, R., & Kelley, K. W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21(2), 153-160.
De La Garza, R. (2005). Endotoxin- or proinflammatory cytokine-induced sickness behavior as an animal model of depression: Focus on anhedonia. Neuroscience and Biobehavioral Reviews, 29(4-5), 761-770.
Descotes, J., & Vial, T. (2007). Flu-like syndrome and cytokines. In R. V. House & J. Descotes (Eds.), Methods in pharmacology and toxicology: Cytokines in human health: Immunotoxicology, pathology, and therapeutic applications (pp. 193-204). Totowa, NJ: Humana Press.
Dodd, M., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 265-470.
Dunn, A. J., Swiergiel, A. H., & de Beaurepaire, R. (2005). Cytokines as mediators of depression: What can we learn from animal studies? Neuroscience and Biobehavioral Reviews, 29(4-5), 891-909.
Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G., & Chrousos, G. P. (2005). Cytokine dysregulation, inflammation, and well-being. Neuroimmunomodulation, 12(5), 255-269.
Haddad, J. J., Saade, N. E., & Safieh-Garabedian, B. (2002). Cytokines and neuro-immune-endocrine interactions: A role for the hypothalamic-pituitaryadrenal revolving axis. Journal of Neuroimmunology, 133(1-2), 1-19.
Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews, 12(2), 123-137.
Harvey, P. O., Pruessner, J., Czechowska, Y., & Lepage, M. (2007). Individual differences in trait anhedonia: A structural and functional magnetic resonance imaging study in non-clinical subjects. Molecular Psychiatry, 12(8), 767-775.
Illman, J., Corringham, R., Robinson, D., Davis, H. M., Rossi, J. F., Cella, D., et al. (2005). Are inflammatory cytokines the common link between cancer-associated cachexia and depression? Journal of Supportive Oncology, 3(1), 37-50.
Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32(6), 1151-1163
Johnson, R. W. (2002). The concept of sickness behavior: A brief chronological account of four key discoveries. Veterinary Immunology and Immunopathology, 87(3-4), 443-450.
Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., et al. (2003). Cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 17(Suppl. 1), S112-S118.
Kim, H. J., McGuire, D. B., Tulman, L., & Barsevick, A. M. (2005). Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nursing, 28(4), 270-282.
Larson, S. J. (2002). Behavioral and motivational effects of immune-system activation. Journal of General Psychology, 129(4), 401-414.
Maier, S. F., & Watkins, L. R. (1998). Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review, 105(1), 83-107.
Maier, S. F., & Watkins, L. R. (2003). Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain, Behavior, and Immunity, 17(Suppl. 1), S125-S131.
Miller, A. H. (2003). Cytokines and sickness behavior: Implications for cancer care and control. Brain, Behavior, and Immunity, 17(Suppl. 1), S132-S134.
Miller, N. E. (1964). Some psychophysiological studies of motivation and of the behavioral effects of illness. Bulletin of the British Psychological Society, 17, 1-20.
Niiya, M., Niiya, K., Kiguchi, T., Shibakura, M., Asaumi, N., Shinagawa, K., et al. (2003). Induction of TNF-α, uPA, IL-8, and MCP-1 by doxorubicin in human lung carcinoma cells. Cancer Chemotherapy and Pharmacology, 52(5), 391-398.
Parnet, P., Kelley, K. W., Bluthe, R. M., & Dantzer, R. (2002). Expression and regulation of interleukin-1 receptors in the brain: Role in cytokines-induced sickness behavior. Journal of Neuroimmunology, 125(1-2), 5-14.
Zaks-Zilberman, M., Zaks, T. Z., & Vogel, S. N. (2001). Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine, 15(3), 156-165.
Lee, B. N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., et al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11(5), 279-292.
Maier, S. F. (2003). Bidirectional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain, Behavior, and Immunity, 17(2), 69-85.